Skip to main content
. 2021 Jul 16;64(9):2052–2060. doi: 10.1007/s00125-021-05492-6

Fig. 3.

Fig. 3

Comparison of GADA levels between RBA and ECL assay in the (a) Action LADA study (n = 771) and (b) DiYA study (n = 2063). The solid dots represent individuals positive for IA-2A and/or ZnT8A and the open dots negative for IA-2A and ZnT8A. The dotted lines indicate assay cut-offs. RBA-GADA was tested at the Blizard Institute laboratory, London, for the Action LADA study, with a cut-off value of 68 (index), and at the Barbara Davis Center for Diabetes laboratory, USA, for the DiYA study, with a cut-off value of 20 (DK units). The ECL-GADA assay was performed at the Barbara Davis Center for Diabetes for both Action LADA and DiYA studies, with a cut-off value of 0.023 (index)